ClinicalTrials.gov retatrutide study listings help verify trial status and sponsor details
After 72 weeks, Zepbound outperformed Wegovy in both primary endpoints and all five secondary endpoints in a study involving adults with obesity or overweight, at least one weight-related health issue, and no diabetes
Harmonizing magnetic mitohormetic regenerative strategies: developmental implications of a calcium-mitochondrial axis invoked by magnetic field exposure
( b-i ) Effects of JMV 2959, PF-05190457, YIL 781, or CDP21 on wild-type ghrelin receptor ( b, d, f, and h ) and N305 7.35 K mutant ( c, e, g, and i )
2001 Aug;73(4):287-97
As nationally recognized educators, researchers, and specialists in corneal disease, refractive surgery, cataract care, and comprehensive ophthalmology, we closely monitor emerging medical research that may affect our patients